Jump to content

High-throughput Screening, Design, Production, and Evaluation of Bispecific Antibodies

PEGS Boston, Boston, MA, USA
April 8, 2019

Work on bispecific antibodies has exploded and more sophisticated engineering approaches are now used. Concurrently, increasing numbers of bispecific platforms (e.g., tandem-scFv-Fc, DVD-Ig, diabodies) and parametric variants (e.g., linkers, V-domain orientation, Fc) must be tested. We present latest advances in our workflow platform for in-format screening (e.g., fully automated molecule design, DNA synthesis, and verification) and platform-specific expression processes (e.g., post production exchange reactions). Integrated into a comprehensive data management system for samples, assays, and analytics results, the platform enables systematic evaluation of large panels of next-generation antibodies.

Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy